Skip to main content

News Archive

News Archive - School of Medicine

Noted Researcher and Scientific Leader Jack E. Dixon Retires

May 27, 2021

Jack E. Dixon, whose distinguished and varied 48-year career ranged from helping reveal how cells communicate to becoming a renowned scientific leader at UC San Diego School of Medicine and Howard Hughes Medical Institute, is retiring.

Cross Border Effort to Vaccinate 10,000 Maquiladora Workers

May 25, 2021

A coalition of six U.S. subsidiary companies have sponsored a COVID-19 mobile clinic to vaccinate 10,000 maquiladora workers employed in Baja California, Mexico. UC San Diego Health is vaccinating about 1,500 workers daily.

Superficial Relationship: Enzymes Protect the Skin by Ignoring Microbes and Viruses

May 21, 2021

UC San Diego School of Medicine researchers identify how the body regulates and prevents constant skin inflammation.

UC San Diego Health Joins Call to Don’t Delay HPV Vaccinations, Save Lives

May 20, 2021

Moores Cancer Center at UC San Diego Health joins other National Cancer Institute cancer centers in urging that HPV vaccinations get back on track as part of cancer prevention. Don’t delay. Save lives.

Older Adults with Functional Impairments Linked to Prescription Drug Use/Misuse

May 20, 2021

Researchers at University of California San Diego School of Medicine found that functional impairments among adults aged 50 and older are associated with a higher risk of medical cannabis use; and prescription opioid and tranquilizer/sedative use and misuse.

New High for Migraine Treatment? Trial Looks at Effectiveness of THC, CBD

May 19, 2021

UC San Diego Health is conducting the first known randomized, double-blind, placebo-controlled clinical trial looking at cannabis as a potentially effective treatment for acute migraines.

Genetic Tools Help Identify a Cellular Culprit for Type 1 Diabetes

May 19, 2021

By mapping its genetic underpinnings, researchers at University of California San Diego School of Medicine have identified a predictive causal role for specific cell types in type 1 diabetes, a condition that affects more than 1.6 million Americans.

Commonly Used Drugs for Schizophrenia Linked to Greater Cognitive Impairment

May 17, 2021

UC San Diego researchers report that medications commonly prescribed to reduce the severity of physical and mental health symptoms associated with schizophrenia may have a cumulative effect of worsening cognitive function in patients.

Using Ultrasound Stimulation to Reduce Inflammation in COVID-19 In-Patients

May 12, 2021

Researchers at UC San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.

Early Screening Tool Leads to Earlier Diagnosis and Treatment for Autism Spectrum Disorder

May 10, 2021

Researchers confirm effectiveness of early screening tool to identify infants with autism, prompting earlier treatment, but key is parental involvement.
Category navigation with Social links